Wednesday 7 September 2016

• 11:00 - Inhibition of the AAA-ATPase p97 with the first in class inhibitor CB-5083 as a novel approach to treat cancer
  Dr Daniel Anderson (Cleave Biosciences)
  Ludwig Institute Seminar Series